Skip to main content

Advertisement

SpringerLink
Log in

Value and utility of disease-specific and generic instruments for assessing disability in patients with migraine, and their relationships with health-related quality of life

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

The aim of this paper is to explore the relationships between health-related quality of life (HRQoL), assessed with the Short Form-36 (SF-36), and disability in adult migraineurs using both disease-specific and generic tools, the WHO Disability Assessment Schedule II (WHO-DAS II) and with the Migraine Disability Assessment questionnaire (MIDAS). Significant differences were observed between patients with minimal/mild and moderate/severe MIDAS disability grades for Role Physical, Bodily Pain, General Health, Vitality, Social Functioning and Physical Composite Score of the SF-36; in the WHO-DAS II for household activities, participation in society and for summary score. WHO-DAS II and MIDAS provide complementary information on the intensity and the frequency of problems in performing daily activities, and could be used jointly. Our findings indicate that these issues are relevant for patients’ health status and should be taken into account in future research on migraine as important secondary outcomes of treatment interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Freitag F (2007) The cycle of migraine: patients’ quality of life during and between migraine attacks. Clin Ther 29:939–949

    Article  PubMed  Google Scholar 

  2. Lipton RB, Liberman JN, Kolodner KB, Bigal ME, Dowson A, Stewart WF (2003) Migraine headache disability and health-related quality-of-life: a population-based case-control study from England. Cephalalgia 23:441–450

    Article  PubMed  CAS  Google Scholar 

  3. Stovner Lj, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27:193–210

    Article  PubMed  Google Scholar 

  4. Bussone G, Usai S, Grazzi L, Rigamonti A, Solari A, D’Amico D (2004) Disability and quality of life in different primary headaches: results from Italian studies. Neurol Sci 25:S105–S107

    Article  PubMed  Google Scholar 

  5. Murray CJL, Lopez AD, Mathers CD, Stein C (2000) WHO Burden Series paper 36: The Global Burden of Disease 2000 project: aims, methods and data sources. WHO, Geneva

  6. World Health Organization (2001) The World Health Report 2001: Mental health, new understanding new hope. WHO, Geneva

  7. Andlin-Sobocki P, Jönsson B, Wittchen HU, Olesen J (2005) Cost of migraine and other headaches in Europe. Eur J Neurol 12:S1–S27

    Article  Google Scholar 

  8. Berg J, Stovner LJ (2005) Cost of migraine and other headaches in Europe. Eur J Neurol 12:S59–S62

    Article  Google Scholar 

  9. Massetto N, Gambini C, Bernardoni P, Ferrante E, Lovati C, Moschiano F, Tonini MC, Bussone G, D’Amico D (2009) Underdiagnosis of primary headaches: results of a survey on patients attending headache centres. Neurol Sci 30:S129–S131

    Article  PubMed  Google Scholar 

  10. Lipton RB, Stewart WF (1993) Migraine in the United States: a review of epidemiology and health care use. Neurology 43:6–10

    Google Scholar 

  11. Freitag F, Smith T, Mathew N, Rupnow M, Greenberg S, Mao L, Finlayson G, Wright P, Biondi D, on behalf of the AEGIS Investigator Study Group (2008) Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS trial. Headache 48:341–354

    Article  PubMed  Google Scholar 

  12. D’Amico D, Solari A, Usai S, Santoro P, Bernardoni P, Frediani F, De Marco R, Massetto N, Bussone G, Progetto Cefalee Lombardia Group (2006) Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study. Cephalalgia 26:691–696

    Article  PubMed  Google Scholar 

  13. Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L (2007) The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health Qual Life Outcomes 5:56

    Article  PubMed  Google Scholar 

  14. Martin BC, Pathak DS, Sharfman MI, Adelman JU, Taylor F, Kwong WJ, Jhingran P (2000) Validity and reliability of the migraine-specific quality of life questionnaire (MSQ version 2.1). Headache 40:204–215

    Article  PubMed  CAS  Google Scholar 

  15. Santanello NC, Hartmaier SL, Epstein RS, Silberstein SD (1995) Validation of a new quality of life questionnaire for acute migraine headache. Headache 35:330–337

    Article  PubMed  CAS  Google Scholar 

  16. Ware JE (2000) SF-36 health survey update. Spine 25:3130–3139

    Article  PubMed  Google Scholar 

  17. Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J (1999) Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia 19:1–96

    Article  Google Scholar 

  18. World Health Organization (2001) The international classification of functioning, disability and health-ICF. WHO, Geneva

  19. Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, Ertas M, Lanteri-Minet M, Reuter U, Del Río MS, Schoenen J, Schwalen S, van Oene J, TOPMAT-MIG-303 Investigators Group (2007) Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 6:1054–1062

    Article  PubMed  CAS  Google Scholar 

  20. Fuh JL, Wang SJ (2006) Comparison of Short Form-36 and migraine disability assessment questionnaire in patients with migraine. Clin J Pain 22:564–568

    Article  PubMed  Google Scholar 

  21. D’Amico D, Usai S, Solari A, Grazzi L, Leone M, Rigamonti A, Bussone G (2003) Relationship between disability and quality of life in migraine. In: Olesen J, Steiner TS, Lipton RB (eds) Reducing the burden of headache. Oxford University Press, New York, pp 75–78

    Google Scholar 

  22. Raggi A, Leonardi M, Ajovalasit D, D’Amico D, Bussone G (2010) Disability and functional profiles of patients with migraine measured with ICF classification. Int J Rehabil Res 32:225–231

    Google Scholar 

  23. Ustun TB (1999) WHO-DAS II field trials report 1998. WHO, Geneva

  24. Cankurtaran ES, Ulug B, Saygi S, Tiryaki A, Akalan N (2005) Psychiatric morbidity, quality of life, and disability in mesial temporal lobe epilepsy patients before and after anterior temporal lobectomy. Epilepsy Behav 7:116–122

    Article  PubMed  CAS  Google Scholar 

  25. Martinuzzi A, Liava A, Trevisi E, Frare M, Tonon C, Malucelli E, Manners D, Kemp GJ, Testa C, Barbiroli B, Lodi R (2008) Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle’s disease. Muscle Nerve 37:350–357

    Article  PubMed  CAS  Google Scholar 

  26. Leonardi M, Raggi A, Antozzi C, Confalonieri P, Maggi L, Cornelio F, Mantegazza R (2010) The relationship between health, disability and quality of life in myasthenia gravis: results from an Italian study. J Neurol 257:98–102

    Article  PubMed  Google Scholar 

  27. Raggi A, Leonardi M, Antozzi C, Confalonieri P, Maggi L, Cornelio F, Mantegazza R (2010) Concordance between severity of disease, disability and health-related quality of life in Myasthenia gravis. Neurol Sci 31:41–45

    Article  PubMed  Google Scholar 

  28. Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders. Cephalalgia 24:S1–S160

    Google Scholar 

  29. D’Amico D, Mosconi P, Genco S, Usai S, Prudenzano AM, Grazzi L, Leone M, Puca FM, Bussone G (2001) The Migraine Disability Assessment (MIDAS) questionnaire: translation and reliability of the Italian version. Cephalalgia 21:947–952

    Article  PubMed  Google Scholar 

  30. Federici S, Meloni F, Mancini A, Lauriola M, Olivetti Belardinelli M (2009) World Health Organisation Disability Assessment Schedule II: contribution to the Italian validation. Disabil Rehabil 31:553–564

    Article  PubMed  Google Scholar 

  31. Apolone G, Mosconi P (1998) The Italian SF-36 health survey: translation, validation and norming. J Clin Epidemiol 51:1025–1036

    Article  PubMed  CAS  Google Scholar 

  32. Stewart WF, Lipton RB, Whyte J, Dowson A, Kolodner K, Liberman JN, Sawyer J (1999) An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 53:988–994

    PubMed  CAS  Google Scholar 

  33. Silberstein SD, Loder E, Forde G, Papadopulos G, Fairclough D, Greenberg S (2006) The impact of migraine on daily activities: effect of topiramate compared with placebo. Curr Med Res Opin 22:1021–1029

    Article  PubMed  CAS  Google Scholar 

  34. Lipton RB, Bigal ME, Stewart WF (2005) Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life. Neurology 65:S50–S58

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The research was part of MHADIE project (Measuring Health and Disability in Europe: supporting policy development), funded by the European Commission, Sixth Framework Programme, contract number SP24-CT-2004-513708 thematic priority ‘Scientific Support to Policies’.

Author information

Authors and Affiliations

  1. Neurology, Public Health and Disability Unit, Scientific Directorate, Neurological Institute C. Besta, IRCCS Foundation, Via Celoria 11, 20133, Milan, Italy

    Alberto Raggi & Matilde Leonardi

  2. Headache Centre, Neurological Institute C. Besta, IRCCS Foundation, Via Celoria 11, 20133, Milan, Italy

    Gennaro Bussone & Domenico D’Amico

Authors
  1. Alberto Raggi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matilde Leonardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gennaro Bussone
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Domenico D’Amico
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alberto Raggi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raggi, A., Leonardi, M., Bussone, G. et al. Value and utility of disease-specific and generic instruments for assessing disability in patients with migraine, and their relationships with health-related quality of life. Neurol Sci 32, 387–392 (2011). https://doi.org/10.1007/s10072-010-0466-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-010-0466-3

Keywords

Search

Navigation